Table 2.
Clinical significance | HBxAg+ (%) | anti-HBx+ (IgG) (%) |
---|---|---|
HBsAg/HBeAg/anti-HBc+ | 21 (91.3)* | 39 (97.5)* |
Anti-HBs+ | 2 (8.7) | 1 (2.5) |
Total | 23 (100) | 40 (100) |
X2 test *P < .01 (versus anti-HBs+).
Clinical significance | HBxAg+ (%) | anti-HBx+ (IgG) (%) |
---|---|---|
HBsAg/HBeAg/anti-HBc+ | 21 (91.3)* | 39 (97.5)* |
Anti-HBs+ | 2 (8.7) | 1 (2.5) |
Total | 23 (100) | 40 (100) |
X2 test *P < .01 (versus anti-HBs+).